To help fight against COVID-19, AMSBIO introduces a new range of SARS-CoV-2 antibodies
and antigens to aid the development of new immunoassay diagnostic kits. Designed for use in a wide range of different antibody detection methods, these antigens are customizable and available in bulk. In addition, AMSBIO has introduced a new range of matched antibody pairs that were specifically designed and screened for antigen detection kit development. Verified against inactivated COVID-19 virus samples, these antibody pairs can be used for the development of diagnostic assays, including chemiluminescent immunoassays, ELISAs, and gold immunochromatography (also known as lateral flow) separations. The company claims the sensitivity of these matched antibody pairs used in a sandwich ELISA kit has been shown to be as low as 12 pg/mL.